Impaired Mycobacterium tuberculosis-specific T-cell memory phenotypes and functional profiles among adults with type 2 diabetes mellitus in Uganda

Front Immunol. 2024 Oct 4:15:1480739. doi: 10.3389/fimmu.2024.1480739. eCollection 2024.

Abstract

Background: Efforts to eradicate tuberculosis (TB) are threatened by diabetes mellitus (DM), which confers a 3-fold increase in the risk of TB disease. The changes in the memory phenotypes and functional profiles of Mycobacterium tuberculosis (Mtb)-specific T cells in latent TB infection (LTBI)-DM participants remain poorly characterised. We, therefore, assessed the effect of DM on T-cell phenotype and function in LTBI and DM clinical groups.

Methods: We compared the memory phenotypes and function profiles of Mtb-specific CD4+ and CD8+ T cells among participants with LTBI-DM (n=21), LTBI-only (n=17) and DM-only (n=16). Peripheral blood mononuclear cells (PBMCs) were stimulated with early secretory antigenic 6 kDa (ESAT-6) and culture filtrate protein 10 (CFP-10) peptide pools or phytohemagglutinin (PHA). The memory phenotypes (CCR7/CD45RA), and functional profiles (HLA-DR, PD-1, CD107a, IFN-γ, IL-2, TNF, IL-13, IL-17A) of Mtb-specific CD4+ and CD8+ T cells were characterised by flow cytometry.

Results: Naïve CD4+ T cells were significantly decreased in the LTBI-DM compared to the LTBI-only participants [0.47 (0.34-0.69) vs 0.91 (0.59-1.05); (p<0.001)]. Similarly, CD8+ HLA-DR expression was significantly decreased in LTBI-DM compared to LTBI-only participants [0.26 (0.19-0.33) vs 0.52 (0.40-0.64); (p<0.0001)], whereas CD4+ and CD8+ PD-1 expression was significantly upregulated in the LTBI-DM compared to the LTBI-only participants [0.61 (0.53-0.77) vs 0.19 (0.10-0.28); (p<0.0001) and 0.41 (0.37-0.56) vs 0.29 (0.17-0.42); (p=0.007)] respectively. CD4+ and CD8+ IFN-γ production was significantly decreased in the LTBI-DM compared to the LTBI-only participants [0.28 (0.19-0.38) vs 0.39 (0.25-0.53); (p=0.030) and 0.36 (0.27-0.49) vs 0.55 (0.41-0.88); (p=0.016)] respectively. CD4+ TNF and CD8+ IL-17A production were significantly decreased in participants with LTBI-DM compared to those with LTBI-only [0.38 (0.33-0.50) vs 0.62 (0.46-0.87); (p=0.004) and 0.29 (0.16-0.42) vs 0.47 (0.29-0.52); (0.017)] respectively. LTBI-DM participants had significantly lower dual-functional (IFN-γ+IL-2+ and IL-2+TNF+) and mono-functional (IFN-γ+ and TNF+) CD4+ responses than LTBI-only participants. LTBI-DM participants had significantly decreased dual-functional (IFN-γ+IL-2+, IFN-γ+ TNF+ and IL-2+TNF+) and mono-functional (IFN-γ+, IL-2+ and TNF+) central and effector memory CD4+ responses compared to LTBI-only participants.

Conclusion: Type 2 DM impairs the memory phenotypes and functional profiles of Mtb-specific CD4+ and CD8+ T cells, potentially indicating underlying immunopathology towards increased active TB disease risk.

Keywords: T cells; diabetes mellitus; functional profiles; latent tuberculosis infection; memory phenotypes.

MeSH terms

  • Adult
  • Antigens, Bacterial / immunology
  • CD4-Positive T-Lymphocytes / immunology
  • CD8-Positive T-Lymphocytes* / immunology
  • Cytokines / metabolism
  • Diabetes Mellitus, Type 2* / immunology
  • Female
  • Humans
  • Immunologic Memory*
  • Latent Tuberculosis* / immunology
  • Male
  • Memory T Cells* / immunology
  • Middle Aged
  • Mycobacterium tuberculosis* / immunology
  • Phenotype
  • Uganda

Substances

  • Cytokines
  • Antigens, Bacterial

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This project is part of the EDCTP2 programme supported by the European Union (grant number RIA2018CO-2514-PROTID), the Government of Uganda through the Uganda Independence Scholarship Trust Fund (UISTF) and the MRC/UVRI and LSHTM Uganda Research Unit, which is jointly funded by the UK Medical Research Council (MRC) part of UK Research and Innovation (UKRI) and the UK Foreign, Commonwealth and Development Office (FCDO) under the MRC/FCDO Concordat agreement and also part of the EDCTP2 programme supported by the European Union. The KTB study was supported by a Wellcome Trust Uganda PhD Fellowship in Infection and Immunity (MUII) held by IB, funded by a Wellcome Trust Strategic Award, grant number 084344, and by the European Community’s Seventh Framework Programme (FP7/2007-2013) under EC-GA number 241642 (the IDEA consortium). The TAD study was supported by postdoctoral fellowships from Makerere University/UVRI Centre of Excellence in Infection and Immunity Research and Training (MUII Plus; grant number 084344) and the MRC/UVRI and LSHTM Uganda Research Unit training grant.